top of page

Myeloma Treatment at Manipal Hospitals


News Desk, News Nation 360 : Multiple myeloma is a type of blood cancer that arises from plasma cells, accounting for 10–15% of blood cancers. At present, the incidence of this type of cancer in India is about 1in 100,000 cases, but recent statistics indicate a probability of an increase in cases in metropolitan cities. March is observed as Multiple Myeloma Awareness Month. On this note, Manipal Hospital organized a press conference today to create widespread awareness of the disease among the general public. Dr Mallikarjun Kalashetty, Consultant - Haematology, Haemato Oncology & Bone Marrow Transplantation, and Dr Ashish Dixit, Consultant - Haematology, Haemato Oncology & Bone Marrow Transplantation, Manipal Hospital Old Airport Road highlighted on the importance of detecting and treating multiple myeloma early to achieve a better prognosis and a good quality of life. The “Bone Marrow Transplant Center” at Manipal Hospital Old Airport Road, Bangalore is the oldest transplantation centre in Karnataka and one of the first few in South India. It offers the best care possible for patients with blood disorders and cancers, led by experienced hemato-oncologists and advanced technology. This state-of-the-art facility manages all kinds of illnesses, both malignant and benign. Both autologous and allogenic transplants, which

include matched sibling donors, matched unrelated donors, and partially matched or haploidentical bone marrow transplantation, are being performed under one roof. The department of haematology in the hospital sees about 50 new cases every month from the eastern part of India, especially West Bengal. Compared to the western world, multiple myeloma affects relatively patients who are younger at diagnosis, thus, patients are likely to have a higher disease burden at diagnosis with more patients suffering from myeloma-associated severe bone disease, renal failure, and spinal cord compression. Patients of Multiple Myeloma suffer from various manifestations like back and bone pain, weakness, fatigue, infections, and renal failure. Because of these varied clinical manifestations, they may end up visiting other speciality doctors and as a result, the diagnosis of multiple myeloma is often delayed. Dr Ashish Dixit says that they have managed these types of cancer with a combination of targeted therapy and stem cell transplants. Proteasome inhibitors are an example of targeted therapy used in multiple myeloma patients. The treatment of myeloma has immensely advanced with the inclusion of immunotherapy, targeted therapies, and monoclonal antibodies, making long-term survival possible with a good quality of life.

Pic : Krishnendu Kundu

Report : Anustup Kundu

bottom of page